• FDA Approves Yupelri as New Treatment for Adults with COPD
  • COPD Foundation Launches App to Help Providers, Patients
  • COPD Patients Begin to Receive Synairgen’s Therapy SNG001 for Flu, Colds in Phase 2 Trial
  • Analysis of Long-term Oxygen Use in Some COPD Patients Makes Researchers Question Its Benefits
  • Long-term Benzodiazepine Use May Increase COPD Patients’ Suicide Risk, Study Suggests
  • FDA Approves New Label for Stiolto Respimat Showing Efficacy Against COPD Flare-ups
  • VA Researchers Working on 3D-Printed Artificial Lung for Patients with COPD, Other Pulmonary Diseases
  • European Panel Recommends Broader Use of Trelegy Ellipta for COPD Patients
  • Daliresp May Ease Lung Inflammation in COPD Patients by Effects on Immune Cells, Trial Data Suggests
  • Investigational PT010 Seen to Improve Lung Function of COPD Patients in Phase 3 Trial
  • Age, Mechanical Ventilation, Disease Severity Influence Hospital Mortality in COPD Patients, Study Says
  • FDA Asks GSK for More Evidence of Mepolizumab’s Ability to Help Treat Flares in COPD Patients